CVRx, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CVRx, Inc. (CVRX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.44 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- CVRx, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 8.43M shares, a 31.16% increase year-over-year.
- CVRx, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 6.42M shares, a 20.20% increase year-over-year.
- CVRx, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 5.34M shares, a 3.93% increase year-over-year.
- CVRx, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 5.14M shares, a 28.34% increase year-over-year.
- CVRx, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 6.32M shares, a 11.79% increase from fiscal 2024.
- CVRx, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.65M shares, a 8.62% increase from fiscal 2023.
- CVRx, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 5.20M shares, a 16.37% increase from fiscal 2022.
- CVRx, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 4.47M shares, a 29.07% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 8.44M shares 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 8.43M shares 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 6.32M shares 10-K · filed 2026-02-13 | |||
| 2025-09-30 | 6.40M shares 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 6.46M shares 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | 6.42M shares 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | 5.65M shares 10-K · filed 2026-02-13 | |||
| 2024-09-30 | 5.95M shares 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | 5.86M shares 10-Q · filed 2025-08-05 | |||
| 2024-03-31 | 5.34M shares 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | 5.20M shares 10-K · filed 2025-02-18 | |||
| 2023-09-30 | 5.18M shares 10-Q · filed 2024-11-01 | |||
| 2023-06-30 | 5.23M shares 10-Q · filed 2024-08-02 | |||
| 2023-03-31 | 5.14M shares 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | 4.47M shares 10-K · filed 2024-02-09 | |||
| 2022-09-30 | 4.44M shares 10-Q · filed 2023-10-31 | |||
| 2022-06-30 | 4.17M shares 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | 4.01M shares 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | 3.47M shares 10-K · filed 2023-02-10 | |||
| 2021-09-30 | 3.37M shares 10-Q · filed 2022-11-04 | |||
| 2021-06-30 | 14.69M shares 10-Q · filed 2022-08-01 | |||
| 2021-03-31 | 14.06M shares 10-Q · filed 2022-05-02 | |||
| 2020-12-31 | 13.51M shares 10-K · filed 2022-02-22 | |||
| 2020-09-30 | 13.00M shares 10-Q · filed 2021-11-08 | |||
| 2020-06-30 | 14.06M shares 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |